China guideline for diagnosis and comprehensive treatment of colorectal liver metastases (version 2023).
10.3760/cma.j.cn441530-20221229-00542
- Collective Name:Chinese College of Surgeons;Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association;Section of Colorectal Surgery, Branch of Surgery, Chinese Medical Association;Colorectal Cancer Professional Committee, Chinese Anti⁃Cancer Association;Colorectal Cancer Professional Committee, Chinese Medical Doctor Association;Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology;Chinese Society of Colon & Rectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association;Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association;Section of Colorectal Oncology, Oncology Branch, Chinese Medical Association;Branch of Metastatic Tumor Therapy, China International Exchange and Promotive Association for Medical and Health Care;Branch of Colorectal Disease, China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Journal Article
- MeSH:
Humans;
Colorectal Neoplasms/pathology*;
Quality of Life;
Liver Neoplasms/secondary*;
China/epidemiology*
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(1):1-15
- CountryChina
- Language:Chinese
-
Abstract:
The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment of colorectal liver metastasis in China, the guidelines have been edited and revised for several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, increase the local damage rate of liver metastases, prolong long-term survival, and improve quality of life. The revised guideline version 2023 includes the diagnosis and follow-up, prevention, multidisciplinary team (MDT), surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, with state-of-the-art experience and findings, detailed content, and strong operability.
